Client: Tachmed
Patients manage chronic conditions on guesswork between clinic appointments. Clinicians make treatment decisions on data that is days old by the time it arrives. Meanwhile, early intervention windows close and health systems absorb the cost of delayed detection.
Tachmed saw the gap differently. Not as a clinical problem but as a distribution one. Laboratory precision exists. It simply lives in the wrong place—locked behind appointment books and laboratory queues. They came with graphene technology capable of measuring biomarkers with clinical accuracy in a device small enough for a home shelf. What it needed was a pathway. One that felt trustworthy to patients using it alone and credible to clinicians reading the results unseen.
Laboratory precision is not a technology problem—it is a distribution one. Put it on the home shelf.
Results were often ambiguous, demanding interpretation or confirmation. Clinicians still had to decode what patients thought they saw, introducing doubt and delay.
Tachmed's real breakthrough was not the sensor. It was immediacy. Data flowing directly from patient to clinician in real time, removing the interpretation gap entirely. A single device reading multiple proprietary chips meant one instrument worked across conditions. No drawer full of single-purpose tools. No mental load on patients choosing which test to run.
Immediacy that removes clinical guesswork. Direct data flow that closes the interpretation gap entirely.
The device had to feel approachable enough for unsupervised use, yet precise enough that results needed no clinical verification. The interface became the bridge. Simple enough that patients felt confident. Rigorous enough that clinicians trusted the output without hesitation.
Electronic reporting to the healthcare provider became automatic, not optional. Data flowed directly into clinical workflows, transforming the test from a patient curiosity into an actionable intelligence system.
Building a bridge between patient confidence and clinical trust. Transforming a curiosity into an actionable intelligence system.
The breakthrough centered on "immediacy"—the ability for graphene-enabled data to flow directly from the patient to the clinician in real-time . By removing the interpretation gap that typically causes doubt in self-testing, we transformed the device from a patient curiosity into a rigorous, actionable intelligence system that fits on a home shelf.
Closing the interpretation gap through real-time, graphene-enabled immediacy.
Early detection becomes routine rather than accidental. Clinicians gain real-time insight instead of historical snapshots. Health systems stop paying for delayed diagnosis and start capturing disease at the point it is most treatable.
For patients, it returns agency. For practitioners, it restores speed. For healthcare economics, it changes the foundations of preventative care.
Agency for the patient and speed for the practitioner. Restoring speed to the foundations of preventative care.
